Legend Biotech Corp. (LEGN)
20.94
-0.88
(-4.03%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
+0.37
(+1.77%)
After-Hours: 20:00
Legend Biotech Max Drawdown (5Y) : 78.24% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 78.24% |
| June 30, 2026 | 78.24% |
| May 31, 2026 | 78.24% |
| April 30, 2026 | 78.24% |
| March 31, 2026 | 78.24% |
| February 28, 2026 | 78.24% |
| January 31, 2026 | 77.12% |
| December 31, 2025 | 72.18% |
| November 30, 2025 | 64.51% |
| October 31, 2025 | 63.80% |
| September 30, 2025 | 63.80% |
| August 31, 2025 | 63.80% |
| July 31, 2025 | 63.80% |
| June 30, 2025 | 63.80% |
| May 31, 2025 | 63.80% |
| April 30, 2025 | 60.46% |
| March 31, 2025 | 58.92% |
| February 28, 2025 | 58.92% |
| January 31, 2025 | 58.92% |
| December 31, 2024 | 57.53% |
| November 30, 2024 | 51.08% |
| October 31, 2024 | 48.37% |
| September 30, 2024 | 48.37% |
| August 31, 2024 | 48.37% |
| July 31, 2024 | 48.37% |
| Date | Value |
|---|---|
| June 30, 2024 | 48.37% |
| May 31, 2024 | 48.37% |
| April 30, 2024 | 45.56% |
| March 31, 2024 | 45.56% |
| February 29, 2024 | 45.56% |
| January 31, 2024 | 45.56% |
| December 31, 2023 | 45.56% |
| November 30, 2023 | 45.56% |
| October 31, 2023 | 45.56% |
| September 30, 2023 | 45.56% |
| August 31, 2023 | 45.56% |
| July 31, 2023 | 45.56% |
| June 30, 2023 | 45.56% |
| May 31, 2023 | 45.56% |
| April 30, 2023 | 45.56% |
| March 31, 2023 | 45.56% |
| February 28, 2023 | 45.56% |
| January 31, 2023 | 45.56% |
| December 31, 2022 | 45.56% |
| November 30, 2022 | 45.56% |
| October 31, 2022 | 45.56% |
| September 30, 2022 | 45.56% |
| August 31, 2022 | 45.56% |
| July 31, 2022 | 45.56% |
| June 30, 2022 | 45.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Dianthus Therapeutics, Inc. | 98.17% |
| Gilead Sciences, Inc. | 26.58% |
| Ironwood Pharmaceuticals, Inc. | 96.33% |
| Arbutus Biopharma Corp. | 84.78% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -22.52 |
| Beta (5Y) | 0.3666 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 54.66% |
| Historical Sharpe Ratio (5Y) | -0.3502 |
| Historical Sortino (5Y) | -0.7784 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.21% |